Previous Article | Next Article ![]()
Molecular and Cellular Biology, November 2006, p. 8539-8550, Vol. 26, No. 22
0270-7306/06/$08.00+0 doi:10.1128/MCB.01053-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Pharmacology and Toxicology,1 Department of Pathology,2 Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, Alabama 35294,3 Division of Infectious Diseases, Children's Hospital, Birmingham, Alabama 35233,4 Division of Endocrinology and Metabolism, University of California, San Diego, La Jolla, California 920935
Received 12 June 2006/ Returned for modification 14 July 2006/ Accepted 30 August 2006
Mechanisms controlling nuclear hormone receptors are a central question to mammalian developmental and disease processes. Herein, we show that a subtle increase in O-GlcNAc levels inhibits activation of nuclear hormone receptors. In vivo, increased levels of O-GlcNAc impair estrogen receptor activation and cause a decrease in mammary ductal side-branching morphogenesis associated with loss of progesterone receptors. Increased O-GlcNAc levels suppress transcriptional expression of coactivators and of the nuclear hormone receptors themselves. Surprisingly, increased O-GlcNAc levels are also associated with increased transcription of genes encoding corepressor proteins NCoR and SMRT. The association of the enzyme O-GlcNAc transferase with these corepressors contributes to specific regulation of nuclear hormone receptors by O-GlcNAc. Overall, transcriptional inhibition is related to the integrated effect of O-GlcNAc by direct modification of critical elements of the transcriptome and indirectly through O-GlcNAc modification of the proteasome.
Published ahead of print on 11 September 2006.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»